Founder Group Limited Announces Pricing of Initial Public Offering 23-10-2024, 10:02

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting 8-12-2025, 05:30

Thai Union Launches SeaChange® 2030, Committing THB 7.2 Billion (USD 200 Million) to Advance Sustainability Goals 18-07-2023, 18:58